SNRPCP10

Across TCGA pan-cancer cohorts, SNRPCP10 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SNRPCP10 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher SNRPCP10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNRPCP10 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LUAD show a favorable association.

BRCA, PAAD, and LUSC are the cancer types where SNRPCP10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
PAAD	OS	Tertile	All	0.700	0.344	.016	30	view →
LUSC	DFS	Tertile	II,III,IV	0.450	0.773	.014	27	view →
MESO	OS	Tertile	III,IV	0.362	0.580	.024	18	view →
LUAD	OS	Tertile	All	0.770	0.666	.033	18	view →
PCPG	OS	Tertile	All	0.773	1.000	.004	15	view →
THYM	DFS	Tertile	II,III,IV	0.399	0.859	.018	12	view →
KIRP	DFS	Tertile	All	1.000	0.891	.005	12	view →
READ	DFS	Quartile	IV	0.282	0.733	.011	9	view →
THCA	DFS	Tertile	IV	0.493	0.876	.019	9	view →
LIHC	DFS	Tertile	All	0.722	0.279	.015	9	view →
LGG	OS	Tertile	All	0.624	0.486	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SNRPCP10–BRCA (DFS)

Open the BRCA breakdown →